Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9NTM9
UPID:
CUTC_HUMAN
Alternative names:
-
Alternative UPACC:
Q9NTM9; Q5TCZ8; Q9Y321
Background:
The Copper homeostasis protein cutC homolog, identified by the accession number Q9NTM9, plays a crucial role in maintaining copper balance within the cell. It has the unique ability to bind one Cu(1+) ion per subunit, highlighting its specificity and importance in copper homeostasis.
Therapeutic significance:
Understanding the role of Copper homeostasis protein cutC homolog could open doors to potential therapeutic strategies. Its pivotal function in copper regulation suggests its involvement in crucial biological processes, making it a target of interest for drug discovery.